1P Minodier,S Robert,G Noel.First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France[J].Arch Pediatr,2005,12(7):1 102-1 108.
2Catherine Cordonnier,Thomas J Walsh,Mark Bresnik.Liposomal Amphotericin B (L-AMB) Is Superior to Amphotericin B Deoxycholate (AmB-d) in Preventing Breakthrough Fungal Infections in Patients with Prolonged Neutropenia and Fever:Results of a Sub-Group Analysis of an Empirical Antifungal Therapy Trial[J].Blood (ASH Annual Meeting Abstracts),2004,104(11):1336.
3E Forestier,V Remy,O Lesens,et al.A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B,caspofungin and voriconazole[J].Eur J Clin Microbiol Infet al Dis,2005,24 (5):347-349.
4Adedayo Adedoyin,Christine E Suenson,Lois E Bolcsak,et al.A pharmacokinetic Study of Amphotericin B Lipid Complex Infet al (Abelcet) in Patients with Definite or Probable Systemic Fungal Infet alions[J].Antimicrob Agents Chemother,2000,44:2 900-2 902.
5M Subira,R Martino,L Gomez,et al.Low-dose amphotericin B lipid complex vs.conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized,controlled trial[J].Eur J Haematol,2004,72 (5):342 -344.
6Rodrigo Martino,Bertrand Dupont,Helen Huckle,et al.No Signs of New Toxicity When Amphotericin B Lipid Complex (ABLC,ABELCET)and Caspofungin Are Used in Combination in the Treatment of FUO[J].Blood (Ash Annual Meeting Abseracts),2004,104 (11):5 077.
7R Bowden,P Chandrasekar,MH White,et al.A double -blind,randomized,controlled trial of Amphoterincin B Colloidal Dispersion versus amphoterincin B for treatment of ivasive as pergillosis in immunocompromised patients[J].Clin Infet al Dis,2002,35 (4):359-366.
8M Doubek,J Mayer,I Lauschova,et al.Comparison of the effect of amphotericin B desoxycholate and amphotericin B Colloidal dispersion on renal functions and renal morphology in rats[J].Nephrology (Carlton),2005,10 (1):57-62.
9Karl V Clemons,Raymond A Sobel,Paul L Williams,et al.Comparative Toxicities and Pharmacokeintics of Intrathecal Lipid (Amphoterincin B Colloidal Dispersion) and Conventional Deoxycholate Formulations of Amphoterincin B in Rabbits[J].Anitimicrob Agents Chemother,2001,45 (2):612-615.
2Jeong YI,Cheon JB,Kim SH,et al.Clonazepam release from core-shell type nanoparticles in vitro[J].J control Rel,1998,51(2-3):169-178.
3Kim JC,Lee EO,Kim JY,et al.Hemolytic and antifungal activity of liposome- entrapped amphotericin B prepared by the precipitation method[J].Pharm Dev Technol,1997,2(3):275-284.
4Neal JC,Stolnik S,Schacht E,et al.In vitro displacement by rat serum of absorbed radiolabeled polocamer and poloxamine copolymer from model and biodegradable nanospheres[J].J Pharm Sci,1998,87(10):1242-1248.
